Senior Director, FP&A
Deciphera Pharmaceuticals
Umowa o pracęPełny etatOpublikowano 8 października 2026
Źródło: Deciphera, a member of Ono Pharmaceutical Co., Ltd., is a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines and providing hope to people living with cancer, neurologic and autoimmune disease. Deciphera is leveraging its proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology to develop a broad portfolio of innovative medicines. In addition to advancing multiple product candidates from Deciphera’s platform in clinical studies, QINLOCK® (ripretinib) is Deciphera’s switch-control kinase inhibitor approved in many countries including the European Union and the United States for the treatment of adult patients with advanced gastrointestinal stromal tumor (GIST) who have received prior treatment with 3 or more kinase inhibitors, including imatinib. ROMVIMZA® (vimseltinib) is a kinase inhibitor approved in the United States for adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will potentially cause worsening functional limitation or severe morbidity, and in the European Union for adult patients with TGCT associated with clinically relevant physical function deterioration and in whom surgical options have been exhausted or would induce unacceptable morbidity or disability.
The spirit of collaboration that has brought medications to life continues to guide how we operate, grow, and discover new breakthroughs. We cultivate an inclusive culture that values curiosity, creativity, and shared accountability—empowering individuals to challenge the unknown together.
Deciphera offers competitive compensation, including equity-based compensation, and a comprehensive benefits package that includes medical, dental, vision, 401(k) retirement plan, life insurance and a flexible spending account for either health care and/or dependent care.
The Senior Director, Financial Planning & Analysis (FP&A) will lead Deciphera’s FP&A function and serve as a key strategic and financial partner to executive leadership, functional leaders, and Ono Pharmaceutical’s corporate headquarters in Japan. This highly visible role is responsible for leading company-wide budgeting, forecasting, and long-range financial planning while ensuring alignment between Deciphera’s business priorities and the broader Ono Pharma Group strategy.
The Senior Director will provide strategic financial leadership and analysis to support portfolio planning, investment decisions, and enterprise-wide resource allocation. Working closely with leaders across Deciphera and Ono Pharma headquarters, this individual will deliver financial insights, challenge key business assumptions, and help drive informed decision-making in support of both short- and long-term corporate objectives. In addition, the role will lead and develop a high-performing FP&A team while advancing the company’s financial planning, reporting, and decision-support capabilities to support continued growth and organizational success.
Deciphera is committed to fair and equitable compensation practices. The base salary pay range for this role is $224,900- $309,200. Actual compensation packages will depend on various factors, including, but not limited to depth of experience, education, skillset, overall performance and/or location.
The spirit of collaboration that has brought medications to life continues to guide how we operate, grow, and discover new breakthroughs. We cultivate an inclusive culture that values curiosity, creativity, and shared accountability—empowering individuals to challenge the unknown together.
Deciphera offers competitive compensation, including equity-based compensation, and a comprehensive benefits package that includes medical, dental, vision, 401(k) retirement plan, life insurance and a flexible spending account for either health care and/or dependent care.
The Senior Director, Financial Planning & Analysis (FP&A) will lead Deciphera’s FP&A function and serve as a key strategic and financial partner to executive leadership, functional leaders, and Ono Pharmaceutical’s corporate headquarters in Japan. This highly visible role is responsible for leading company-wide budgeting, forecasting, and long-range financial planning while ensuring alignment between Deciphera’s business priorities and the broader Ono Pharma Group strategy.
The Senior Director will provide strategic financial leadership and analysis to support portfolio planning, investment decisions, and enterprise-wide resource allocation. Working closely with leaders across Deciphera and Ono Pharma headquarters, this individual will deliver financial insights, challenge key business assumptions, and help drive informed decision-making in support of both short- and long-term corporate objectives. In addition, the role will lead and develop a high-performing FP&A team while advancing the company’s financial planning, reporting, and decision-support capabilities to support continued growth and organizational success.
Deciphera is committed to fair and equitable compensation practices. The base salary pay range for this role is $224,900- $309,200. Actual compensation packages will depend on various factors, including, but not limited to depth of experience, education, skillset, overall performance and/or location.
